2021-March-1 01:15
Society_Culture
2020-December-8  14:15

Iran Starts Human Trial of Coronavirus Vaccine

TEHRAN (FNA)- Iran announced on Tuesday the start of the human trial of its home-made vaccine, noting that it will be tested on different volunteers in 3 phases.

“The human trial of the home-grown coronavirus vaccine has started and the volunteers will be monitored for one month to study the results,” Spokesman of Iran's Food and Drug Organization Kianoush Jahanpour told FNA.

He noted that the vaccine will be injected to volunteers, between the age of 18 to 50 with negative coronavirus tests, twice, and added, “After the injection, the antibody and immunity levels of the volunteers will be checked.”


Spokesman of Iran's Food and Drug Organization Kianoush Jahanpour

Jahanpour stated that in the second and third phases of the human trial of the Iran-made coronavirus vaccine more volunteers will be tested, saying that the vaccine will receive the necessary license for mass-production if it proves effective.

Last week, Iran's Health Minister Saeed Namaki expressed the hope that the country's home-made coronavirus vaccine will be ready for production by spring.

Efforts are underway to produce the vaccine domestically with the help of knowledge-based companies, Namaki said on Wednesday.

He added that one of the knowledge-based companies received a license for human trial, noting that if these efforts continue, Iran we will be one of the leading producers of vaccine in the region and will be able to meet its needs by the spring.

Namaki had announced in November that the World Health Organization (WHO) has confirmed results of coronavirus vaccine tests of 4 Iranian companies, adding that the country would start the human trial phase of the vaccine next week.

“The WHO has accepted the progress of 4 (Iranian) companies and a company has received license for human trial and the human trial phase will start next week and I hope that we can announce production of the domestic vaccine to the dear people within the next few months,” Namaki said.